Access cutting-edge bladder pain syndrome treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access bladder pain syndrome specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder pain syndrome treatment provided free
This is an open-label study that will enroll participants with Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS). The study will assess PRN (as needed) dosing of up to 6 intravesical (via catheter) doses of VNX001 (study drug) to treat acute instances of moderate to severe bladder pain over a 14-day period. The main aim of the study is to tally the number of doses and assess pain before and after doses. The study will review the safety and tolerability of VNX001. Participants will need to
Sponsor: Vaneltix Pharma, Inc.
Check if you qualify for this bladder pain syndrome clinical trial in Fresno, CA
If you're searching for bladder pain syndrome treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder pain syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.